Men starting testosterone replacement therapy often have a specific concern: will TRT make me go bald faster? The answer is not a straightforward yes or no. TRT’s effect on hair loss depends heavily on genetic predisposition, baseline DHT levels, and whether hair loss prevention measures are used alongside therapy. This article breaks down what the evidence actually shows, what risk factors increase hair loss likelihood on TRT, and what options exist to protect your hairline while managing low testosterone.
What Causes Hair Loss in Men on TRT
Testosterone replacement therapy raises total testosterone levels in the body. A portion of that testosterone is converted to dihydrotestosterone (DHT) by the enzyme 5-alpha reductase. ( 1 ) DHT is the primary hormonal driver of androgenetic alopecia: in genetically susceptible men, it binds to androgen receptors in scalp follicles and causes progressive miniaturization.
When TRT elevates testosterone levels, it can increase the substrate available for DHT conversion, potentially raising DHT concentrations in the scalp. For men who are genetically predisposed to hair loss, this can accelerate or unmask a thinning pattern that would have eventually developed anyway. ( 2 ) For men without the genetic predisposition, the DHT increase from TRT is unlikely to cause significant hair loss.
It is worth noting that the relationship between low testosterone and hair loss is not protective. Men with clinically low testosterone can still experience androgenetic alopecia if their follicles are genetically sensitive to whatever DHT is present.
The Science: TRT, DHT, and Follicle Sensitivity
Not all testosterone preparations affect DHT conversion equally. Research comparing different TRT formulations has shown that transdermal gels and creams, when applied to the skin, result in higher local DHT conversion compared to injectable testosterone. ( 3 ) A study published in the Journal of Clinical Endocrinology and Metabolism found that men using transdermal testosterone had significantly higher DHT levels than those using intramuscular injections at comparable testosterone targets.
The extent of hair loss risk also depends on which type of 5-alpha reductase is most active in a man’s scalp. Type II 5-alpha reductase, the primary isoform responsible for scalp DHT production, is the target of finasteride. Men with high type II activity may experience more pronounced hair loss acceleration on TRT. ( 4 )
Genetic variants in the androgen receptor gene further modulate the outcome. Research published in Annals of Human Genetics identified specific AR gene polymorphisms associated with both early-onset androgenetic alopecia and heightened androgen sensitivity, meaning some men are at substantially higher risk than others when DHT levels rise. ( 5 )
For context on how testosterone levels relate to health markers over time, see our article on normal testosterone levels by age.
Treatment Options for Hair Loss on TRT
Hair loss is not an inevitable consequence of TRT, and several strategies can reduce risk or address thinning that does develop.
Finasteride Alongside TRT
Finasteride inhibits type II 5-alpha reductase, reducing the conversion of testosterone to DHT. For men on TRT who are genetically predisposed to hair loss, adding finasteride can significantly blunt the hair-loss-accelerating effect of elevated testosterone. In clinical practice, this combination is used by many men’s health physicians when hair loss is a documented concern. ( 6 ) A prescribing physician should evaluate whether this combination is appropriate based on individual hormonal goals and history.
Adjusting TRT Formulation
Switching from a transdermal gel or cream to an injectable formulation may reduce DHT conversion in some men, given the pharmacokinetic differences between delivery routes. ( 7 ) This is a decision to make in collaboration with the prescribing physician rather than unilaterally, as injection timing and testosterone peaks require careful management.
Topical Minoxidil
Minoxidil does not affect DHT but can support hair follicle activity independently. Adding minoxidil to a treatment regimen while on TRT addresses the cellular mechanisms of hair growth without interfering with hormonal therapy. It is available over the counter and is supported by strong clinical evidence for slowing hair loss and stimulating regrowth. ( 8 )
Monitoring Hair Loss Progress
Baseline photography and regular check-ins with a dermatologist allow men on TRT to track whether hair loss is accelerating. Early detection means earlier intervention and better outcomes.
Common Myths About TRT and Hair Loss
Myth: TRT always causes hair loss. TRT accelerates hair loss only in men with genetic predisposition. Men without significant androgenetic alopecia susceptibility often experience no meaningful hair changes on TRT. ( 9 )
Myth: Stopping TRT will reverse hair loss. Once follicular miniaturization has progressed significantly, restoring pre-TRT hormone levels does not recover lost hair. Prevention is far more effective than reversal.
Myth: Low testosterone protects hair. DHT sensitivity at the follicle, not total testosterone levels, determines hair loss risk. Low testosterone does not eliminate hair loss susceptibility.
Myth: You have to choose between TRT and your hair. With appropriate co-management using finasteride or other DHT-reducing strategies, many men successfully maintain their hair while optimizing testosterone levels.
When to See a Doctor
If you are being evaluated for TRT or already on testosterone therapy and have a personal or family history of significant hair loss, raise this proactively with your physician. A proactive plan, including potentially starting a DHT blocker before or alongside TRT, is more effective than trying to manage accelerated hair loss after it has begun. ( 10 )
Men considering TRT for the first time should also understand the broader implications of therapy, including effects on fertility. Our article on TRT and fertility covers that dimension in detail and is worth reading before starting treatment.
Protect Your Hair While Optimizing Your Hormones
TRT and a full head of hair are not mutually exclusive goals. The key is understanding your genetic risk, choosing the right formulation, and co-managing with evidence-based hair loss treatments when appropriate. If you are weighing TRT or managing its effects, work with a men’s health physician who takes both hormonal optimization and hair health seriously as part of a complete treatment plan.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213–1215. https://doi.org/10.1126/science.186.4170.1213
- Trüeb RM. Molecular mechanisms of androgenetic alopecia. Experimental Gerontology. 2002;37(8–9):981–990. https://doi.org/10.1016/S0531-5565(02)00093-1
- Swerdloff RS, Wang C. Transdermal testosterone delivery. Journal of Clinical Endocrinology and Metabolism. 1999;84(10):3400–3405. https://doi.org/10.1210/jcem.84.10.6047
- Kaufman KD. Androgens and alopecia. Molecular and Cellular Endocrinology. 2002;198(1–2):89–95. https://doi.org/10.1016/S0303-7207(02)00372-5
- Hillmer AM, Hanneken S, Ritzmann S, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American Journal of Human Genetics. 2005;77(1):140–148. https://doi.org/10.1086/431425
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4):578–589. https://doi.org/10.1016/S0190-9622(98)70007-6
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2010;95(6):2536–2559. https://doi.org/10.1210/jc.2009-2354
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology. 2004;150(2):186–194. https://doi.org/10.1111/j.1365-2133.2004.05785.x
- Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998;317(7162):865–869. https://doi.org/10.1136/bmj.317.7162.865
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2010;95(6):2536–2559. https://doi.org/10.1210/jc.2009-2354